Company
Headquarters: Bangkok, Thailand
CEO: Mr. Thiti Sihanatkathakul
฿6.30 Billion
THB as of July 1, 2024
US$171.5 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Thai Nakarin Hospital Public Company Limited engages in the hospital business in Thailand. The company offers medical services in the areas of heart, bone and joint, holistic oncology, hemodialysis, skin and laser, traditional Chinese medicine, ear, nose, throat, pediatrics, obstetrics, gynecology, medicine, dental, surgery, emergency, physical therapy, gastrointestinal, breast care, lasik, diabetes, endocrinology, brain, neurology, hepato-biliary, pancreas, X-ray, and eye, as well as operates kidney transplant and check-up centers. Thai Nakarin Hospital Public Company Limited was founded in 1993 and is based in Bangkok, Thailand.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Thai Nakarin Hospital Public Company Ltd has the following listings and related stock indices.
Stock: SET: TNH wb_incandescent
Stock: SET: TNH.R wb_incandescent